Verlukast
Alternative Names: L 668019; MK 0679; MK 679; R-(-)-MK 571Latest Information Update: 27 Jul 1994
At a glance
- Originator Merck & Co
- Class Antiasthmatics
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma